Galapagos N.V.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Company name change signals strategic shift; investors need to know the new name to track stock correctly.
Stocky reads Galapagos N.V.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Galapagos N.V.'s most recent tracked filing was a 424B3 on 8 May 2026: Galapagos rebrands to Lakefront Biotherapeutics.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.